Understand how to commercialise via partnering in Europe and other markets ...

Access to venture capital and effective fundraising tactics are key to buil...

One might think that planning for uncertainty is something that biotech fir...

For the first seven months of this year (to July) our Deal Watch analysis o...

Artificial Intelligence (AI) systems hold great potential in taking on an i...

Securing external investment is an undisputed priority for senior managemen...

The leadership landscape within life sciences is beginning to change. More ...

The 2018 C-Suite Challenges in Life Sciences Survey from Biotech & Money/LS...

An acquisition in the life sciences sector raises various issues, some of w...

Experience drug development – designed around you®

Heraclitus, the Greek philosopher, who said: “change is the only constant i...

In early 2017, LSX, formerly Biotech and Money, published the inaugural Inv...